Prior Treatment Time Affects Survival Outcomes in Metastatic Breast Cancer

PURPOSE: Sequential drug treatments in metastatic breast cancer (MBC) are disparate. Clinical trial data includes limited reporting of treatment context, primarily including the number of prior therapies. This study evaluates the relationship between prior treatment time, prior lines of treatment, a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JCO Clin Cancer Inform
Main Authors: Rocque, Gabrielle B., Gilbert, Aidan, Williams, Courtney P., Kenzik, Kelly M., Nakhmani, Arie, Kandhare, Pravinkumar G., Bhatia, Smita, Burkard, Mark E., Azuero, Andres
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2020
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7444642/
https://ncbi.nlm.nih.gov/pubmed/32479187
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/CCI.20.00008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados